|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Debt Securities, Available-for-Sale | ||||||||||||||||||||
| Mortgage Loans (net of allowance for credit losses of $16.4; $15.9) | ||||||||||||||||||||
| Policy Loans | ||||||||||||||||||||
| Other Long-term Investments | ||||||||||||||||||||
| Short-term Investments | ||||||||||||||||||||
| Total Investments | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Cash and Bank Deposits | ||||||||||||||||||||
| Accounts and Premiums Receivable (net of allowance for credit losses of $26.7; $26.1) | ||||||||||||||||||||
| Reinsurance Recoverable (net of allowance for credit losses of $0.5; $1.4) | ||||||||||||||||||||
| Accrued Investment Income | ||||||||||||||||||||
| Deferred Acquisition Costs | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Property and Equipment | ||||||||||||||||||||
| Deferred Income Tax | ||||||||||||||||||||
| Income Taxes Receivable | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Future Policy Benefits | ||||||||||||||||||||
| Policyholders' Account Balance | ||||||||||||||||||||
| Unearned Premiums | ||||||||||||||||||||
| Other Policyholders’ Funds | ||||||||||||||||||||
| Income Tax Payable | ||||||||||||||||||||
| Deferred Income Tax | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Long-term Debt | ||||||||||||||||||||
| Other Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Common Stock, $0.10 par; authorized: 725,000,000 shares; issued: 196,724,958 and 196,194,941 shares | ||||||||||||||||||||
| Additional Paid-in Capital | ||||||||||||||||||||
| Accumulated Other Comprehensive Loss | ||||||||||||||||||||
| Retained Earnings | ||||||||||||||||||||
| Treasury Stock - at cost: 40,523,985 and 30,500,524 shares | ||||||||||||||||||||
| Total Stockholders' Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders' Equity | ||||||||||||||||||||
Loading...